Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05757908 · ClinicalTrials.gov registry record · NA
Study Comparing At-Home Mobile Spirometry to In-Clinic in Moderate Asthma Participants Taking Long-Acting Beta Agonist
A NA study of Moderate Asthma, sponsored by Koneksa Health.
- Completed
- Registry status
- NA
- Development phase
- 29
- Enrollment target
- 9
- Study locations
NCT05757908 is a NA study of Moderate Asthma that has completed, run by Koneksa Health. The registered enrollment target is 29 participants. The trial reports 9 study locations across 7 states.
The verdict
NCT05757908, a NA study of Moderate Asthma, has completed, sponsored by Koneksa Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 29 participants
- Enrollment target
- 9
- Study locations
Study Summary
The goal of this interventional study is to compare at-home mobile spirometry to in-clinic spirometry in participants with moderate asthma while taking a long-acting beta agonist (LABA). The main questions it aims to answer are: * Do at-home mobile spirometry and in-clinic spirometry assessments show a similar treatment effect (measured changes in FEV1) with the addition of LABA? * Is at-home mobile spirometry as accurate as in-clinic spirometry in showing treatment effects (changes in FEV1)? Participants will be asked to: * Take standard of care LABA treatment once or twice a day * Complete at-home mobile spirometry testing twice a day * Complete asthma questionnaires twice a day * Complete device use questionnaires * Wear a wrist device (like a watch) to track physical activity and vital signs * Visit the clinic for in-clinic spirometry testing once a week for 8 weeks
Conditions Studied
Interventions
- DRUG Long-Acting Beta Agonist
Study Locations (9)
South Carolina
- Clinical Research of Rock Hill - Rock Hill
- Spartanburg Medical Research - Spartanburg
Texas
- El Paso Pulmonary Association - El Paso
- South Texas Allergy & Asthma Medical Professionals Research - San Antonio
Alabama
- AllerVie Research Clinic - Birmingham
Georgia
- AllerVie Research Clinic - Columbus
Massachusetts
- Northeast Medical Research Associates, Inc. - North Dartmouth
Nebraska
- The Asthma & Allergy Center, PC - Bellevue
North Carolina
- American Health Research - Charlotte
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 29 participants |
| Start Date | 2023-04-21 |
| Est. Completion | 2023-11-29 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05757908
The ClinicalTrials.gov registry entry for NCT05757908 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 29 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Koneksa Health, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Moderate Asthma appearing as the primary indexed condition, and to 1 intervention - of which Long-Acting Beta Agonist is the first listed.
NCT05757908 reports 9 study locations spanning 7 distinct geographic areas - top geographies include South Carolina, Texas, Alabama.
Frequently Asked Questions
What is clinical trial NCT05757908 about?
NCT05757908 is a clinical study titled "Study Comparing At-Home Mobile Spirometry to In-Clinic in Moderate Asthma Participants Taking Long-Acting Beta Agonist". The goal of this interventional study is to compare at-home mobile spirometry to in-clinic spirometry in participants with moderate asthma while taking a long-acting beta agonist (LABA). The main questions it aims to answer are: * Do at-home mobile spirometry and in-clinic spirometry assessments s...
What is the current status of trial NCT05757908?
This trial is currently completed. It is a NA study. The enrollment target is 29 participants. The study started on 2023-04-21. Estimated completion is 2023-11-29.
What conditions does trial NCT05757908 study?
This clinical trial studies the following conditions: Moderate Asthma.
What interventions are being tested in trial NCT05757908?
The interventions under investigation include: Long-Acting Beta Agonist (DRUG).
Who is sponsoring clinical trial NCT05757908?
This trial is sponsored by Koneksa Health, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05757908 being conducted?
This trial has 9 study locations across Alabama, Georgia, Massachusetts, Nebraska, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.